Landec Sees Q3 EPS $0.06-$0.09 May Not Compare To $0.19 Est., Sales $154M-$158M vs $162.25M Est.

Excluding restructuring and nonrecurring charges, the Company is reiterating its full year fiscal 2020 guidance, which is detailed below: Revenues from continuing operations to grow 8% to 10% (range of $602 million to

Benzinga · 01/02/2020 21:08

Excluding restructuring and nonrecurring charges, the Company is reiterating its full year fiscal 2020 guidance, which is detailed below:

  • Revenues from continuing operations to grow 8% to 10% (range of $602 million to $613 million) compared to fiscal 2019
  • Earnings per share to be $0.28 to $0.32
  • Cash flow from operations to be $26 million to $30 million
  • Consolidated EBITDA to be in the range of $36 million to $40 million

The Company is introducing third quarter fiscal 2020 guidance, excluding restructuring and non-recurring charges as follows:

  • Revenues from continuing operations to be in the range of $154 million to $158 million compared to third quarter of fiscal 2019
  • Net income per share of $0.06 to $0.09, due to certain shipments for Lifecore shifting from the fiscal third quarter to the fiscal fourth quarter, Yucatan working through the last of its high-cost products and starting to sell more of its lower-cost products that have been produced since October and a portion of the cost out savings for the fiscal third quarter being delayed to the fiscal fourth quarter
  • EBITDA to be in the range of $7 million to $11 million